683 Capital Management’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

683 Capital Management’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,000	Closed	-$9.76K	–	304
2023 Q1	$9.76K	Hold	1,000	–	–	﹤0.01%	273
2022 Q4	$9.77K	Hold	1,000	–	–	﹤0.01%	271
2022 Q3	$10K	Hold	1,000	–	–	﹤0.01%	215
2022 Q2	$10K	Hold	1,000	–	–	﹤0.01%	250
2022 Q1	$10K	Hold	1,000	–	–	﹤0.01%	350
2021 Q4	$10K	Hold	1,000	–	–	﹤0.01%	343
2021 Q3	$10K	Sell	1,000 -199,000	-100%	-$1.99M	﹤0.01%	214
2021 Q2	$2.01M	Buy	+200,000	New	+$2.02M	0.07%	124

683 Capital Management's ORIAU Position: Q2 2023 in Review

683 Capital Management sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q2 2023, closing a stake of 1,000 shares — an estimated $9.76K sold.

683 Capital Management first reported a position in ORIAU in Q2 2021 and held it in 8 quarters. The position peaked at $2.01M in Q2 2021. 0 funds tracked by Wall St. Rank hold ORIAU as of Q2 2023.

683 Capital Management reported no remaining Orion Biotech Opportunities Corp. Units position as of Q2 2023 after selling out during the quarter.
683 Capital Management sold 1,000 Orion Biotech Opportunities Corp. Units shares in Q2 2023, an estimated $9.76K.
683 Capital Management first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 8 quarters.
683 Capital Management's Orion Biotech Opportunities Corp. Units position peaked at $2.01M in Q2 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q2 2023.

Based on 683 Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.